KEY AREAS OF FOCUS
Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.
The TIDES Europe 2024 hybrid program features scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.
Oligonucleotide Chemistry, Manufacturing & Controls
Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
Oligonucleotide Discovery, Preclinical and Clinical
Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Chemistry, Manufacturing & Controls
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
Peptide Discovery, Preclinical and Clinical
Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
mRNA Therapeutics and Genome Editing
Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies
Macromolecular Drug Delivery
Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing
Save 15% with VIP Code 欧美AV15 at checkout!
